1. India Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Choksi Asia Ltd

Choksi Asia Ltd

BBSE:CHOKSI
213.15
INR
-6.55
(-2.98%)
9.10EPS
18.16P/E
942.39MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
436.43
277
117.86
69.9
59.18
44.44
41.03
29.17
6.32
1.84
273.32
648.79
86.43
81.81
Basic EPS, GAAP
-16.58
1.08
5.56
1.97
3.3
2.19
-1.42
4.89
-1.08
-1.22
24.33
54.37
9.36
9.1
Free Cash Flow per Basic Share
39.4
26.96
19.89
4.22
14.08
6.21
-6.47
-22.84
-1.44
-6.45
47.02
-50.33
1.3
- -
Dividend per Share
- -
0.5
1
- -
0.75
0.75
0.5
- -
2.5
- -
- -
- -
- -
- -
Book Value per Share
32.52
31.3
36.21
38.17
40.55
41.84
39.8
44.69
41.01
39.79
85.78
94.56
73.85
- -
Tangible Book Value per Share
32.38
31.1
36.06
38.07
40.48
41.78
39.77
44.66
40.99
39.75
61.92
70.71
57.54
- -
Basic Weighted Avg Shares
4
4
4
4
4
4
4
4
4
4
1
1
6
6
Sales/Revenue/Turnover
1,702
1,080
460
273
231
173
160
114
25
7
156
370
493
466
Operating Margin (%)
-1.87
1.93
6.53
3.3
5.14
1.83
-0.85
6.7
-39.12
-223.15
-0.79
9.95
13.24
13.91
Depreciation Expense
6
4
4
4
2
2
2
2
2
2
2
2
3
3
Net Income, GAAP
-65
4
22
8
13
9
-6
19
-4
-5
14
31
53
52
Effective Tax Rate (%)
- -
- -
0.73
22.59
29.8
14.88
- -
29.48
- -
- -
7.4
34.44
28.9
31.06
Profit Margin (%)
-3.8
0.39
4.72
2.82
5.57
4.94
-3.47
16.77
-17.17
-66.15
8.9
8.38
10.82
11.13
Working Capital
20
19
38
51
64
73
72
105
92
91
175
240
247
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
14
30
2
- -
Total Equity
127
122
141
149
158
163
155
174
160
155
335
369
421
- -
Return on Invested Capital (%)
- -
- -
15.54
1.35
5.19
3.85
- -
6.55
- -
- -
-0.43
6.06
10.79
- -
Return on Capital (%)
- -
- -
15.49
5.29
8.37
5.33
- -
11.58
- -
- -
6.65
8.61
13.16
- -
Return on Common Equity (%)
-40.62
3.38
16.47
5.29
8.37
5.33
-3.49
11.58
-2.53
-3.02
5.67
8.81
13.51
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
17
- -
LT Borrowings
- -
2
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
6
Market Capitalization
609
689
942

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
290
- -
Cash, Cash Equivalents & STI
- -
61
- -
Accounts Receivable, Net
- -
95
- -
Inventories
- -
92
- -
Total Current Liabilities
- -
44
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
17
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.1%
25.76%
14.17%
Free Cash Flow
-13.69%
-56.89%
-125.81%
Net Income, GAAP
-94.5%
-61.21%
72.12%
Sales/Revenue/Turnover
197.2%
417.9%
33.25%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
77
84
87
122
370
2026
119
133
123
119
493
2027
92
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
3.93
1.67
0.53
1.82
54.37
2026
2.75
2.36
3.73
1.32
9.36
2027
1.69
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Samir Kanubhai Choksi
Full Time Employees
12
Sector
Health technology
Industry
Medical specialties
Address
163/164 Choksi Bhuvan Mumbai MP India 400057
IPO Date
Mar 23, 1995
Website
choksiworld.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Choksi Asia Limited (formerly Choksi Imaging Limited) manufactures and sells photosensitized materials and related products for the healthcare and industrial sectors in India. The company offers portable ultrasound systems under the K-magic and eSaote brand names for obstetrics/gynecology, abdominal, cardiovascular, and general-purpose applications; ultrasound accessories including transesophageal, pencil doppler, convex, volumetric convex, micro-convex, linear, endocavity, and phased array probes; X-ray films and chemicals such as laser green, laser blue, and laser chemical products; X-ray accessories comprising screens, cassettes, illuminators, and aprons; laser NDT chemicals for processing industrial X-ray film; and trades in specialty X-ray films and medical equipment. It also provides non-destructive testing (NDT) products, including Iridium-192, Selenium-75, and Cobalt-60 sources; industrial radiography equipment from brands like SPEC and Oserix; Teledyne ICM X-ray generators; and SILFLEX shielding materials. Founded in 1992 and headquartered in Mumbai, India, at 163/164 Choksi Bhuvan, Nehru Road, Vile Parle East, the company operates primarily in the medical imaging and industrial radiography segments, serving healthcare providers, diagnostic centers, and industrial clients across India. In April 2025, the company changed its name from Choksi Imaging Limited to Choksi Asia Limited and updated its stock symbol to CHOKSI.BO, following approval of a scheme of amalgamation with Choksi Asia Private Limited by the National Company Law Tribunal, Mumbai. Recent developments include significant revenue growth to Rs 3,698.16 lakhs in fiscal year 2024-2025 from Rs 1,809.02 lakhs previously, driven by business expansion; director appointments such as Krishnakumar Parikh as non-executive independent director in 2024 and Brijal Mitesh Desai as non-executive independent woman director in 2023; and board meetings for unaudited results through December 2024, reflecting ongoing operational enhancements and strong stock performance with upper circuit hits in late 2025.